Bausch Health Companies (BHC) Projected to Post Quarterly Earnings on Wednesday

Bausch Health Companies (NYSE:BHC) is projected to issue its quarterly earnings data after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $1.65 per share and revenue of $2.51 billion for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Bausch Health Companies Trading Up 0.9 %

NYSE BHC opened at $6.38 on Wednesday. Bausch Health Companies has a 1 year low of $3.96 and a 1 year high of $11.46. The company has a fifty day simple moving average of $7.59 and a 200 day simple moving average of $7.46. The company has a market cap of $2.31 billion, a P/E ratio of -13.29, a P/E/G ratio of 0.34 and a beta of 0.68.

Wall Street Analyst Weigh In

A number of research firms have issued reports on BHC. Jefferies Financial Group restated a “hold” rating and set a $8.00 price target (down from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th. Royal Bank of Canada decreased their target price on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a research note on Thursday, January 30th. StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a research report on Friday, October 25th. Finally, Evercore ISI raised Bausch Health Companies to a “hold” rating in a research report on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.